Jazz Other Current Assets from 2010 to 2025

JAZZ Stock  USD 138.95  1.27  0.91%   
Jazz Pharmaceuticals Other Current Assets yearly trend continues to be fairly stable with very little volatility. Other Current Assets are likely to outpace its year average in 2025. Other Current Assets is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. View All Fundamentals
 
Other Current Assets  
First Reported
2005-12-31
Previous Quarter
509.3 M
Current Value
439 M
Quarterly Volatility
115.4 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Jazz Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jazz Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 250 M, Other Operating Expenses of 3.5 B or Operating Income of 752.5 M, as well as many indicators such as Price To Sales Ratio of 1.78, Dividend Yield of 0.0 or PTB Ratio of 1.77. Jazz financial statements analysis is a perfect complement when working with Jazz Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Jazz Pharmaceuticals Correlation against competitors.

Latest Jazz Pharmaceuticals' Other Current Assets Growth Pattern

Below is the plot of the Other Current Assets of Jazz Pharmaceuticals PLC over the last few years. It is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. Jazz Pharmaceuticals' Other Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jazz Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Other Current Assets10 Years Trend
Slightly volatile
   Other Current Assets   
       Timeline  

Jazz Other Current Assets Regression Statistics

Arithmetic Mean169,461,356
Geometric Mean53,469,983
Coefficient Of Variation112.41
Mean Deviation168,399,320
Median76,686,000
Standard Deviation190,485,457
Sample Variance36284.7T
Range505.9M
R-Value0.90
Mean Square Error7246.2T
R-Squared0.81
Slope36,089,082
Total Sum of Squares544270.6T

Jazz Other Current Assets History

2025460.9 M
2024439 M
2023506.3 M
2022359.1 M
2021383.8 M
2020214.9 M
201978.9 M

About Jazz Pharmaceuticals Financial Statements

Jazz Pharmaceuticals investors use historical fundamental indicators, such as Jazz Pharmaceuticals' Other Current Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jazz Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Assets439 M460.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.